Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 50
  • Start Date: November 2021
Efficacy of Mini-pool Intravenous Immunoglobulin (MP-IVIG) Prepared by Assiut University Hospital Blood Bank in Guillain-Barré Syndrome
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Biological
  • Participants: 120
  • Start Date: January 2021
NEUROKINASE : Expression Profile of ERK5 and PKM2 Kinases in Neuroinflammatory Diseases.
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Biological
  • Participants: 18
  • Start Date: November 2020
Phase I Trial To Evaluate The Safety Of CK0801 In Treatment-Resistant Guillain-Barré Syndrome (GBS)
Clinical Trial
  • Status: Recruiting
  • Participants: 200
  • Start Date: April 27, 2020
An Observational Cohort Study on the Efficacy of Intravenous Gamma Globulin on Guillain-Barre Syndrome
Clinical Trial
  • Status: Recruiting
  • Participants: 200
  • Start Date: January 1, 2020
New Biomarkers in Acute and Chronic Inflammatory Demyelinating Polyradiculoneuropathies
Clinical Trial
  • Status: Enrolling by invitation
  • Phase: N/A
  • Intervention Type: Diagnostic Test
  • Participants: 50
  • Start Date: September 30, 2019
Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome: A Pilot Study
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Diagnostic Test
  • Participants: 100
  • Start Date: July 1, 2019
Early Prediction of Respiratory and Autonomic Complications of GBS Using Neuromuscular Ultrasound
Clinical Trial
  • Status: Recruiting
  • Participants: 500
  • Start Date: September 8, 2014
Recovery After Cerebral Hemorrhage--Improving Outcomes for Patients With Life-Threatening Neurologic Illness
Showing 1-12 of 13